As President Donald Trump’s wealth has soared since retaking office, a new financial disclosure shows his two premier Florida ...

June 22 () - ‌Pfizer ‌said on ​Monday its drug ‌for ⁠a type ⁠of ​lung ​cancer ​missed ‌the main goal ‌of ​a ​late-stage ...

PFE trades at just 8x forward earnings while paying a near-7% dividend yield, and the five-year base case model targets $49. Pfizer's Berobenatide GLP-1 posted 16% weight loss at 32 weeks with no ...

President Donald Trump lashed out at CNN anchor and Chief White House Correspondent Kaitlan Collins once again, accusing her of having “hatred in her eyes,” while he spoke to reporters in the Oval ...

President Trump on Wednesday attacked CNN’s Kaitlan Collins, accusing her of having “hatred in her eyes,” while he took questions from reporters in the Oval Office. The president was answering a ...

In a press availability in the Oval Office, Trump called CNN “a very corrupt organization” and then referred to Collins, who was there asking questions, as “a corrupt reporter standing right there, ...

Five bite-sized IP updates from the week, also featuring rising recognition of the MADE IN BRITAIN mark, and a settled Nike/Converse “Love” dispute. Register for free to receive our newsletter, view ...

Innovent to receive $650 mln upfront, up to $9.85 bln in milestone payments Innovent leads Phase 1 development; Pfizer takes over global development thereafter Follows Pfizer's earlier licensing deal ...

CNN is suing Perplexity, accusing the AI company of unlawfully copying and distributing CNN’s content. Thursday’s lawsuit joins a long list of legal actions by publishers like The New York Times ...

CNN is shaking up its early mornings — tapping “CNN Headline Express” anchor Brad Smith to temporarily helm the network’s 5 a.m. ET hour as the cable giant leans harder into its streaming-first ...

Higher sales of cancer treatments helped fuel better-than-expected first-quarter sales and profit for drugmaker Pfizer PFE1.36%increase; up pointing triangle. Pfizer also reaffirmed its sales and ...

Pfizer posted first-quarter earnings and revenue that topped estimates and reaffirmed its 2026 outlook, as recently launched and acquired products showed growth. Older top-selling drugs, including its ...